Spero Therapeutics (SPRO) News Today $1.32 +0.06 (+4.76%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$1.25▼$1.3450-Day Range$1.00▼$1.3252-Week Range$0.99▼$2.04Volume218,627 shsAverage Volume158,257 shsMarket Capitalization$69.96 millionP/E Ratio132.00Dividend YieldN/APrice Target$7.00 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineSpero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 14 at 1:01 PMSpero Therapeutics, Inc.: Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Updatefinanznachrichten.de - November 14 at 8:00 AMRecap: Spero Therapeutics Q3 Earningsbenzinga.com - November 13 at 8:46 PMSpero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Updatefinance.yahoo.com - November 13 at 8:46 PMSpero Therapeutics Q3 2023 Earnings Previewmsn.com - November 12 at 8:55 PMHere's what Wall Street expects from Spero Therapeutics's earnings reportmarkets.businessinsider.com - November 12 at 3:30 PMSpero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023finance.yahoo.com - November 6 at 11:29 AMSPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firmbusinesswire.com - November 2 at 10:58 PMSpero Therapeutics to Present at Upcoming November Investor Conferencesfinance.yahoo.com - November 1 at 8:43 PMSpero Therapeutics, Inc.: Spero Therapeutics Appoints Esther Rajavelu as Chief Financial Officer and Chief Business Officerfinanznachrichten.de - November 1 at 10:42 AMAll You Need to Know About Spero Therapeutics, Inc. (SPRO) Rating Upgrade to Buyfinance.yahoo.com - October 18 at 2:11 PMSpero Therapeutics to Present at Cantor’s Global Healthcare 2023 Investor Conferencefinance.yahoo.com - September 20 at 8:20 PMInsider Sell: Chief Medical Officer Kamal Hamed Sells 39,496 Shares of Spero Therapeutics Incfinance.yahoo.com - September 16 at 3:52 PMSpero Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 9:23 AM4 Analysts Have This to Say About Spero Therapeuticsmarkets.businessinsider.com - September 5 at 6:22 PMSpero Therapeutics (SPRO) Price Target Increased by 5.26% to 6.80msn.com - August 31 at 8:21 PMSpero Therapeutics, Inc. (SPRO) Upgraded to Strong Buy: What Does It Mean for the Stock?finance.yahoo.com - August 29 at 6:55 PMDown -11.72% in 4 Weeks, Here's Why Spero Therapeutics, Inc. (SPRO) Looks Ripe for a Turnaroundfinance.yahoo.com - August 22 at 9:16 PMAlaunos (TCRT) to Wind Down Sole Clinical Study, Stock Dips 65%nasdaq.com - August 16 at 2:15 PMHC Wainwright & Co. Maintains Spero Therapeutics (SPRO) Buy Recommendationmsn.com - August 14 at 8:28 PMHC Wainwright & Co. Maintains Buy Rating for Spero Therapeutics: Here's What You Need To Knowmarkets.businessinsider.com - August 14 at 3:26 PMSpero Therapeutics, Inc. (NASDAQ:SPRO) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 13 at 2:43 PMQ2 2023 Spero Therapeutics Inc Earnings Callfinance.yahoo.com - August 11 at 6:05 PMSpero Therapeutics Announces Second Quarter 2023 Operating Results and Provides a Business Updatefinance.yahoo.com - August 10 at 5:02 PMSpero Therapeutics earnings: here's what Wall Street expectsmarkets.businessinsider.com - August 9 at 8:41 PMSpero Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023finance.yahoo.com - August 3 at 2:59 PMH.C. Wainwright Reaffirms Their Buy Rating on Spero Therapeutics (SPRO)markets.businessinsider.com - August 1 at 7:44 PMSpero Therapeutics shares rise on FDA approval of pivotal complicated UTI trialproactiveinvestors.com - July 31 at 4:05 PMSpero Therapeutics in Special Protocol Assessment Agreement for Phase 3 Trial of Tebipenem HBrmarketwatch.com - July 31 at 11:04 AMSpero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBrfinance.yahoo.com - July 31 at 11:04 AMSpero Therapeutics (SPRO) Receives a Buy from H.C. Wainwrightmarkets.businessinsider.com - July 20 at 10:25 AMSPRO - Spero Therapeutics, Inc.ca.finance.yahoo.com - July 18 at 7:28 PMInvestors in Spero Therapeutics (NASDAQ:SPRO) have unfortunately lost 90% over the last three yearsfinance.yahoo.com - July 5 at 10:08 AMSpero Therapeutics, Inc.: Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)finanznachrichten.de - July 1 at 8:27 AM3 Pharma Stocks Every Investor Should Knowentrepreneur.com - June 15 at 1:08 PMSpero Therapeutics, Inc.: Spero Therapeutics Appoints Sath Shukla as President & Chief Executive Officerfinanznachrichten.de - June 14 at 9:43 AMSpero CEO to step down; new CEO to turn focus toward lung disease antibioticbizjournals.com - June 14 at 9:43 AMSpero Therapeutics Appoints Sath Shukla as President & Chief Executive Officerfinance.yahoo.com - June 14 at 9:43 AMTime To Worry? Analysts Are Downgrading Their Spero Therapeutics, Inc. (NASDAQ:SPRO) Outlookfinance.yahoo.com - May 18 at 7:51 AMSpero Therapeutics, Inc. (NASDAQ:SPRO) Q1 2023 Earnings Call Transcriptfinance.yahoo.com - May 16 at 3:26 PMQ1 2023 Spero Therapeutics Inc Earnings Callfinance.yahoo.com - May 12 at 9:04 AMSpero Therapeutics, Inc.: Spero Therapeutics Announces First Quarter 2023 Operating Results and Provides a Business Updatefinanznachrichten.de - May 12 at 4:04 AMRecap: Spero Therapeutics Q1 Earningsmsn.com - May 11 at 11:03 PMSpero Therapeutics Announces First Quarter 2023 Operating Results and Provides a Business Updatefinance.yahoo.com - May 11 at 6:03 PMSpero Therapeutics Q1 2023 Earnings Previewseekingalpha.com - May 10 at 10:01 PMSpero Therapeutics's Earnings Outlookmsn.com - May 10 at 4:54 PMSpero Therapeutics to Provide Business Update and Report First Quarter 2023 Financial Results on Thursday, May 11, 2023finance.yahoo.com - May 4 at 9:58 AMSpero Therapeutics, Inc.'s (NASDAQ:SPRO) Price Is Right But Growth Is Lacking After Shares Rocket 26%finance.yahoo.com - April 17 at 10:15 AMSpero Therapeutics to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious Diseasesfinance.yahoo.com - April 14 at 8:11 AMIndustry Analysts Just Upgraded Their Spero Therapeutics, Inc. (NASDAQ:SPRO) Revenue Forecasts By 40%finance.yahoo.com - April 13 at 10:53 AM Get Spero Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRO and its competitors with MarketBeat's FREE daily newsletter. Email Address SPRO Media Mentions By Week SPRO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SPRO News Sentiment▼0.000.51▲Average Medical News Sentiment SPRO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SPRO Articles This Week▼01▲SPRO Articles Average Week Get Spero Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Incannex Healthcare News Gyre Therapeutics News Hillstream BioPharma News Ocuphire Pharma News NGM Biopharmaceuticals News InflaRx News Leap Therapeutics News Aclaris Therapeutics News Kezar Life Sciences News SCYNEXIS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:SPRO) was last updated on 12/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.